SC
CBPO

Sculptor Capital’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Sculptor Capital’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-103,496
Closed -$11M – 420
2016
Q2 		$11M Buy
+103,496
New +$12M 0.06% 190

Other funds holding CBPO

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sculptor Capital's CBPO Position: Q3 2016 in Review

Sculptor Capital sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2016, closing a stake of 103,496 shares — an estimated $11M sold.

Sculptor Capital first reported a position in CBPO in Q2 2016 and held it in 1 quarter. The position peaked at $11M in Q2 2016. 162 funds tracked by Wall St. Rank hold CBPO as of Q3 2016.

  • Sculptor Capital reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2016 after selling out during the quarter.
  • Sculptor Capital sold 103,496 China Biologic Products Holdings, Inc. shares in Q3 2016, an estimated $11M.
  • Sculptor Capital first reported a position in China Biologic Products Holdings, Inc. in Q2 2016 and held it in 1 quarter.
  • Sculptor Capital's China Biologic Products Holdings, Inc. position peaked at $11M in Q2 2016.
  • 162 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2016.

Based on Sculptor Capital's 13F filing for Q3 2016, filed 10 Nov 2016.